Vladlen V. Bazylev

Vladlen V. Bazylev

Auto-generated profile, based on publicly available information

Vladlen V. Bazylev

Федеральное государственное бюджетное учреждение «Федеральный центр сердечно-сосудистой хирургии» Министерства здравоохранения Российской Федерации

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2021 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
ICI. I. Chernov
I. I. Chernov
Soslan Taisumovich EnginoevSoslan Taisumovich Enginoev
Soslan Taisumovich Enginoev
RKRoman Komarov
Roman Komarov
VBV. V. Bazylev
V. V. Bazylev
DTD. G. Tarasov
D. G. Tarasov
KZKonstantin Zhigalov
Konstantin Zhigalov
Непосредственные результаты операции Ozaki: многоцентровое исследование

20 November 2018 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
ВБВ. В. Базылев
В. В. Базылев
AVA. Voyevodin
A. Voyevodin
AZA. Zakharova
A. Zakharova
ERE. Rosseykin
E. Rosseykin
АВА. Б. Воеводин
А. Б. Воеводин
АЗА. С. Захарова
А. С. Захарова
Background. The obvious expansion of mini-invasive technologies is looming large in surgical treatment of heart diseases. Hundreds of thousands of transcatheter aortic valve replacement procedures have been performed in the world today. The improvement in quality and the increase in life expectancy in cohorts of patients who until recently have been considered inoperable are now routinely achievable. A significant limitation of this method for Russian clinics is the absence of domestic transcatheter implantable prosthetic heart valves on the market. During the last five years, such devices have been developed at “MedEng” (Penza, Russia) scientific and production enterprise. We present the first Russian transcatheter aortic valve prosthesis, its leaflets made of polytetrafluoroethylene, components of the delivery system and implantation, as well as the hospital outcomes of clinical trials. Aim. To evaluate the clinical and hemodynamic results of transcatheter aortic valve implantation using a “MedLab-KT” prosthesis during hospital stay.Methods. A prospective study included 54 patients who underwent transcatheter repair of the aortic valve using a “MedLab-KT” prosthesis. To evaluate the frequency of complications, myocardial infarction, strokes, bleeding, deaths during hospital stay and gradient indices on the prosthesis, postoperative ultrasound examination data were obtained and analyzed. Results. The results are comparable with those achieved by using the foreign models known from literature. Conclusion. The clinical and hemodynamic results of using the “MedLab-KT” aortic valve prosthesis can be considered as satisfactory. Funding: The study had no sponsorship. Conflict of interest: The authors declare no conflict of interest. Authors’ contributionConception and study design: V.V. Bazylev, E.V. Rosseykin, A.B. VoevodinData collection and analysis: A.B. Voevodin, A.S. ZakharovaStatistical analysis: A.B. VoevodinDrafting the article: A.B. VoevodinCritical revision of the article: A.B. VoevodinFinal approval of the version to be published: V.V. Bazylev, A.B. Voevodin, A.S. Zakharova, E.V. Rosseykin ORCID IDV.V. Bazylev, https://orcid.org/0000-0001-6089-9722A.B. Voevodin, https://orcid.org/0000-0002-7078-1274A.S. Zakharova, https://orcid.org/0000-0001-7239-2945E.V. Rosseykin, https://orcid.org/0000-0003-0784-2246

20 September 2019 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
VBV. V. Bazylev
V. V. Bazylev
AVA. B. Voevodin
A. B. Voevodin
ASA. S. Shalygina
A. S. Shalygina
Среднесрочные результаты транскатетерной имплантации протеза аортального клапана «МедЛаб-КТ»

1 January 2019 in Angiology and vascular surgery
Verified
Journal Article
Closed access
ERE. V. Rosseĭkin
E. V. Rosseĭkin
EKE. E. Kobzev
E. E. Kobzev
VBV. V. Bazylev
V. V. Bazylev
Implantation of a mechanical or biological graft remains the gold standard in treatment of patients with aortic valve pathology. However, the necessity of taking anticoagulants, the problem of graft durability, the risk for thromboembolic and haemorrhagic complications, prosthetic infective endocarditis impel surgeons to search for and develop new technologies. One of such new techniques is prosthetic repair of the aortic valve using autologous pericardium according to the S. Ozaki operation. This procedure makes it possible to form an aortic valve with excellent haemodynamic characteristics and low frequency of re-do operations in both the early and remote periods. Current trends are towards exponential growth of minimally invasive cardiosurgical interventions. Upper partial sternotomy is one of the most commonly used techniques in surgery of the aortic valve. The results of previous studies demonstrated that a minimally invasive approach apart from a good cosmetic effect has a series of advantages over full sternotomy by the in-hospital and remote outcomes. On the other hand, a minimally invasive access is associated with limited surgical exposure and tight operative field and is therefore technically more complicated than the operation via full sternotomy. In our retrospective study we compared the clinical outcomes of the minimally invasive Ozaki technique (Ozaki Mini Group, n=30) and full sternotomy (Ozaki Full Group, n=112). Because of differences between the groups by the clinical and demographic parameters in order to ensure maximum comparability we conducted computer-assisted propensity score matching, resulting in formation of 2 groups consisting of 30 patients each. The primary outcome measures of the study were 30-day all-cause mortality and postoperative major adverse cardiac events (myocardial infarction, stroke). As additional categorical outcomes we examined new-onset atrial fibrillation and renal failure, resternotomy, prolonged (>24 h) assisted artificial pulmonary ventilation, mediastinitis/sternal instability. Secondary outcome measures were as follows: the duration of the operation, duration of myocardial ischaemia and artificial circulation, blood loss, requirement for transfusion of donor blood components.

9 September 2015 in Multimedia Manual of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
ACAleksei E. Chernogrivov
Aleksei E. Chernogrivov
AGAlexandr A. Gornostaev
Alexandr A. Gornostaev
ICIgor E. Chernogrivov
Igor E. Chernogrivov
PTPetr N. Toschev
Petr N. Toschev
SSShakhriiar F. Suleimanov
Shakhriiar F. Suleimanov
VBVladlen V. Bazylev
Vladlen V. Bazylev
Anomalous origin of the right coronary artery from the pulmonary artery is rare (only 200 cases have been reported in total), potentially life-threatening and with an uncertain prognosis. Patient characteristics are only available in half the reported cases. Easy to miss, anomalous origin of the right coronary artery from the pulmonary artery (ARCAPA) is usually diagnosed in association with concomitant cardiac anomalies. Techniques for its correction are rarely discussed, but the restoration of a two-coronary system is optimal. We report details of the surgical repair of ARCAPA in a 17-year-old man to highlight important anatomical features.

7 September 2018 in Asian Cardiovascular and Thoracic Annals
Verified
Journal Article
Closed access
EREvgeny Rosseykin
Evgeny Rosseykin
EKEvgeny Kobzev
Evgeny Kobzev
VBVladlen Bazylev
Vladlen Bazylev
Here we propose a new method of aortic cannulation in type A aortic dissection and aortic arch aneurysms. Aortic cannulation is performed through any of the ostia of brachiocephalic arteries and has been successfully used in 77 patients. This procedure is simple, safe, effective, and might be used as one of the alternatives to the classic methods of arterial cannulation.